{"nct_id":"NCT00034619","title":"A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.","status":"COMPLETED","status_verified_date":"2006-07","start_date":null,"start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":null,"completion_date_type":null,"phases":["PHASE2"],"tickers":["LLY"]}